Bristol-Myers Squibb Company (BMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 8,040,000 | 6,345,000 | 7,014,000 | -8,995,000 | 3,460,000 |
| Depreciation Amortization | 9,760,000 | 10,276,000 | 10,686,000 | 10,380,000 | 1,746,000 |
| Income taxes - deferred | -3,288,000 | -2,738,000 | -1,393,000 | 983,000 | -924,000 |
| Accounts receivable | -995,000 | -663,000 | -1,054,000 | -646,000 | 752,000 |
| Other Working Capital | -1,914,000 | -2,229,000 | -1,261,000 | 987,000 | 3,170,000 |
| Other Operating Activity | 2,257,000 | 2,075,000 | 2,215,000 | 11,343,000 | 6,000 |
| Operating Cash Flow | $13,860,000 | $13,066,000 | $16,207,000 | $14,052,000 | $8,210,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -1,041,000 | 2,819,000 | -1,282,000 | 2,108,000 | -152,000 |
| PPE Investments | -1,209,000 | -1,118,000 | -973,000 | -753,000 | -836,000 |
| Net Acquisitions | -260,000 | -2,981,000 | -862,000 | -12,343,000 | -9,092,000 |
| Sale Of Investment | 215,000 | 218,000 | 2,579,000 | 129,000 | 167,000 |
| Investing Cash Flow | $-2,295,000 | $-1,062,000 | $-538,000 | $-10,859,000 | $-9,913,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -120,000 | 194,000 | -160,000 | -267,000 | 131,000 |
| Debt Issued | 4,455,000 | 5,926,000 | 0 | 6,945,000 | 26,778,000 |
| Debt Repayment | -3,879,000 | -11,431,000 | -6,022,000 | -2,750,000 | -9,256,000 |
| Common Stock Repurchased | -5,155,000 | -8,001,000 | -6,287,000 | -1,546,000 | -7,300,000 |
| Dividend Paid | -4,744,000 | -4,634,000 | -4,396,000 | -4,075,000 | -2,679,000 |
| Other Financing Activity | 27,000 | 984,000 | 641,000 | 542,000 | -53,000 |
| Financing Cash Flow | $-9,416,000 | $-16,962,000 | $-16,224,000 | $-1,151,000 | $7,621,000 |
| Exchange Rate Effect | 45,000 | -33,000 | -102,000 | 111,000 | -9,000 |
| Beginning Cash Position | 9,325,000 | 14,316,000 | 14,973,000 | 12,820,000 | 6,911,000 |
| End Cash Position | 11,519,000 | 9,325,000 | 14,316,000 | 14,973,000 | 12,820,000 |
| Net Cash Flow | $2,194,000 | $-4,991,000 | $-657,000 | $2,153,000 | $5,909,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 13,860,000 | 13,066,000 | 16,207,000 | 14,052,000 | 8,210,000 |
| Capital Expenditure | -1,209,000 | -1,118,000 | -973,000 | -753,000 | -836,000 |
| Free Cash Flow | 12,651,000 | 11,948,000 | 15,234,000 | 13,299,000 | 7,374,000 |